Adage Capital Partners’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-500,000
Closed -$10.4M 1132
2021
Q1
$10.4M Buy
500,000
+13,897
+3% +$321K 0.02% 663
2020
Q4
$11.1M Buy
+486,103
New +$9.26M 0.02% 563
2020
Q2
Sell
-300,000
Closed -$3.56M 816
2020
Q1
$3.56M Sell
300,000
-850,000
-74% -$18.8M 0.01% 613
2019
Q4
$28.6M Buy
1,150,000
+250,000
+28% +$5.07M 0.07% 306
2019
Q3
$15.3M Buy
900,000
+400,000
+80% +$7.28M 0.04% 433
2019
Q2
$11.4M Buy
500,000
+400,000
+400% +$10.8M 0.03% 505
2019
Q1
$3.21M Sell
100,000
-200,000
-67% -$6.19M 0.01% 633
2018
Q4
$8.45M Buy
300,000
+150,000
+100% +$4.39M 0.02% 536
2018
Q3
$4.31M Buy
+150,000
New +$4.51M 0.01% 646
2018
Q2
Sell
-500,000
Closed -$19.6M 809
2018
Q1
$19.6M Sell
500,000
-169,632
-25% -$6.2M 0.05% 395
2017
Q4
$21.7M Buy
669,632
+169,632
+34% +$5.09M 0.05% 390
2017
Q3
$15.6M Sell
500,000
-100,006
-17% -$2.96M 0.04% 469
2017
Q2
$16.8M Sell
600,006
-400,000
-40% -$9.06M 0.04% 450
2017
Q1
$17.1M Buy
1,000,006
+68,018
+7% +$953K 0.04% 429
2016
Q4
$11.3M Buy
931,988
+531,988
+133% +$6.89M 0.03% 510
2016
Q3
$6.34M Buy
400,000
+225,649
+129% +$3.4M 0.02% 585
2016
Q2
$2.25M Buy
+174,351
New +$2.73M 0.01% 636
2014
Q4
Sell
-150,000
Closed -$2.33M 778
2014
Q3
$2.33M Buy
+150,000
New +$2.26M 0.01% 669

Other funds holding XENT

Adage Capital Partners's XENT Position: Q2 2021 in Review

Adage Capital Partners sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 500,000 shares — an estimated $10.4M sold.

Adage Capital Partners first reported a position in XENT in Q3 2014 and held it in 18 quarters. The position peaked at $28.6M in Q4 2019. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

  • Adage Capital Partners reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
  • Adage Capital Partners sold 500,000 Intersect ENT, Inc shares in Q2 2021, an estimated $10.4M.
  • Adage Capital Partners first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 18 quarters.
  • Adage Capital Partners's Intersect ENT, Inc position peaked at $28.6M in Q4 2019.
  • 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.